Literature DB >> 3390217

Effect of PCR 4099 on ADP-induced calcium movements and phosphatidic acid production in rat platelets.

R Feliste1, M F Simon, H Chap, L Douste-Blazy, G Defreyn, J P Maffrand.   

Abstract

Antiplatelet activity of PCR 4099, an analogue of ticlopidine, resides in its specific effect against exogenous as well as released ADP. This study investigated in rat platelets the effects of the drug on ADP-induced shape change, elevation of cytosolic free Ca2+ concentration ([Ca2+]i) and hydrolysis of inositol phospholipids, monitored as [32P]phosphatidic acid formation. Shape change and influx of Ca2+ ions across the plasma membrane were not modified after PCR 4099 administration using aspirin-treated platelets. On the other hand, phosphatidic acid formation and calcium mobilization from internal stores were strongly inhibited. These results suggest that PCR 4099 leaves intact the machinery involved in ADP-induced platelet shape change and influx of calcium ions, but inhibits an early step in the ADP-response coupling leading to inositol phospholipid hydrolysis and aggregation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3390217     DOI: 10.1016/0006-2952(88)90246-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  3 in total

Review 1.  Pleiotropic effects of clopidogrel.

Authors:  Dawn S Kuszynski; D Adam Lauver
Journal:  Purinergic Signal       Date:  2022-06-09       Impact factor: 3.950

2.  Sub-second oscillations of inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate during platelet activation by ADP and thrombin: lack of correlation with calcium kinetics.

Authors:  S Raha; G D Jones; A R Gear
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

3.  The human platelet ADP receptor activates Gi2 proteins.

Authors:  P Ohlmann; K L Laugwitz; B Nürnberg; K Spicher; G Schultz; J P Cazenave; C Gachet
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.